Reuters logo
BRIEF-KemPharm Q2 loss per share $0.44
August 10, 2017 / 9:00 PM / a month ago

BRIEF-KemPharm Q2 loss per share $0.44

Aug 10 (Reuters) - Kempharm Inc

* KemPharm Inc reports second quarter 2017 results

* Q2 loss per share $0.44

* Q2 earnings per share view $-0.63 -- Thomson Reuters I/B/E/S

* KemPharm Inc says now expect to file Investigational New Drug (IND) application for KP484 as early as Q3 of 2017 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below